FDAの審査と製薬企業の資金提供:完治より継続治療?
45 sec Machine translated Health
45 sec Machine translated Health
問題は ええと FDAが独占していることです門番の役をしていますはい彼らがあなたに求めることは莫大な資金と資源を必要とします ― はいそれを持てるのは大手製薬会社— はい
それに バイオ企業も大手製薬会社も長期的に利益が出るものにしか資金を出したがりませんだから治療法は商売になりません「これで治る」というものはあまり好まれませんええと もしずっと
飲み続けなければならない薬を開発したなら彼らはずっと乗り気になりますそう そう そうだから— でも 私たちには分かりません問題を解決するものを探そうと— ええ ええ
単に治すだけではなく
End of transcript · 144 words · machine translated
The, the issue is that, um, uh, that, uh, the FDA has a monopoly, right? They act as the gatekeeper.
Yes. And really what they're asking you to do are things that require an incredible amount of money and resources- Yes ... which only really big pharmaceuticals- Yes ... are very well-healed biotech companies have.
And, um, biotech, big pharma, they often only wanna fund things that are going to have longevity. So cures are not good business.
So things that are like, "Oh, this fixes it," no so, not so good.
Um, if, if you came up with something where they'd have to, like, constantly be taking this drug for life, they're a lot more excited about that.
Right, right, right. So- Well, and we don't know ... try to find the things that solve it- Yeah, yeah ... without just curing.
TranslateMom transcribes and translates videos from X, TikTok, YouTube and Instagram. Paste a link and you get a page like this one, in your language.